CHG-2022-0223

Specification Change for Tiotropizone. Formulation Change for Tiotropizone — critical change. Impacts 5 markets and 1 variations.

Change Number
CHG-2022-0223
Type
Specification Change
Product
Tiotropizone
Status
Draft
Owner
Marcus Webb
Initiated
2022-12-31
Description

Formulation Change for Tiotropizone — critical change

Impacted Markets (5)
CA — CanadaGB — United KingdomIT — ItalyIN — IndiaPT — Portugal
Impacted Modules
4.2.12.3.P3.2.S
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved